185 related articles for article (PubMed ID: 22231327)
1. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
Teng PR; Lane HY
J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
[No Abstract] [Full Text] [Related]
2. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
Hou YC; Lai CH
J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786
[No Abstract] [Full Text] [Related]
3. Possible paliperidone-induced neuroleptic malignant syndrome: a case report.
Özdemir A; Aksoy-Poyraz C; Kılıç-Yener E
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E22-3. PubMed ID: 23037666
[No Abstract] [Full Text] [Related]
4. Catatonia and encephalopathy associated with paliperidone palmitate.
Coffey MJ
J Clin Psychopharmacol; 2012 Apr; 32(2):284-5. PubMed ID: 22388156
[No Abstract] [Full Text] [Related]
5. Paliperidone-induced neuroleptic malignant syndrome.
Nayak RB; Bhogale GS; Patil NM; Chate SS; Pandurangi AA; Shetageri VN
J Neuropsychiatry Clin Neurosci; 2011; 23(1):E14-5. PubMed ID: 21304113
[No Abstract] [Full Text] [Related]
6. Possible neuroleptic malignant syndrome associated with paliperidone.
Duggal HS
J Neuropsychiatry Clin Neurosci; 2007; 19(4):477-8. PubMed ID: 18070861
[No Abstract] [Full Text] [Related]
7. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
Mantas C; Kalabokis G; Goulia P; Tourlakopoulos A; Hyphantis T; Mavreas V
J Clin Psychopharmacol; 2010 Feb; 30(1):89-91. PubMed ID: 20075663
[No Abstract] [Full Text] [Related]
8. Two cases of risperidone-induced neuroleptic malignant syndrome.
Dave M
Am J Psychiatry; 1995 Aug; 152(8):1233-4. PubMed ID: 7542837
[No Abstract] [Full Text] [Related]
9. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
Han C; Lee SJ; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
[No Abstract] [Full Text] [Related]
10. Neuroleptic malignant syndrome with risperidone.
Levin GM; Lazowick AL; Powell HS
J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
[No Abstract] [Full Text] [Related]
11. Risperidone and NMS?
Murray S; Haller E
Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
[No Abstract] [Full Text] [Related]
12. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
[TBL] [Abstract][Full Text] [Related]
13. Risperidone/paliperidone induced neutropenia and lymphopenia.
Raj V; Druitt T; Purushothaman S; Dunsdon J
Aust N Z J Psychiatry; 2013 Mar; 47(3):291-2. PubMed ID: 22984110
[No Abstract] [Full Text] [Related]
14. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
Hsu WY; Chiu NY
J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
[No Abstract] [Full Text] [Related]
15. Risperidone-induced neuroleptic malignant syndrome.
Webster P; Wijeratne C
Lancet; 1994 Oct; 344(8931):1228-9. PubMed ID: 7523815
[No Abstract] [Full Text] [Related]
16. Two cases of risperidone-induced neuroleptic malignant syndrome.
Singer S; Richards C; Boland RJ
Am J Psychiatry; 1995 Aug; 152(8):1234. PubMed ID: 7542838
[No Abstract] [Full Text] [Related]
17. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
Meterissian GB
Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
[TBL] [Abstract][Full Text] [Related]
18. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.
Suzuki Y; Fukui N; Watanabe J; Ono S; Sugai T; Tsuneyama N; Saito M; Inoue Y; Someya T
Hum Psychopharmacol; 2012 Jan; 27(1):39-42. PubMed ID: 22144033
[TBL] [Abstract][Full Text] [Related]
19. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
Guanci N; Aggarwal R; Schleifer S
Psychosomatics; 2012; 53(6):603-5. PubMed ID: 23157999
[No Abstract] [Full Text] [Related]
20. Manic symptoms during a switch from risperidone to paliperidone: a case report.
Yang FW; Liang CS
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E29. PubMed ID: 21948917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
